The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy

FASEB Journal

Volumn 23, Issue 7, 2009, Pages 2120-2130

  Defer, Nicole ^a,b   Wan, Jinghong ^a,b   Souktani, Richard ^b,c   Escoubet, Brigitte ^d,f   Perier, Magali ^a,b   Caramelle, Philippe ^a,b   Manin, Sylvie ^a,b   Deveaux, Vanessa ^a,b   Bourin, Marie Claude ^a,b   Zimmer, Andreas ^e   Lotersztajn, Sophie ^a,b   Pecker, Françoise ^a,b   Pavoine, Catherine ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c Plate Forme Petit Animal ^*  (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF BONN   (Germany)

^f BICHAT HOSPITAL   (France)

Author keywords

Apoptosis; Fibrosis; Heart failure; In vivo; Remodeling; Signaling

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; CANNABINOID 2 RECEPTOR; HYDROGEN PEROXIDE; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL ACTIVATION; CELL DEATH; CELL ISOLATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FIBROBLAST; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; TARGET CELL; WILD TYPE; ANIMAL; CYTOLOGY; HEART LEFT VENTRICLE FUNCTION; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOMYOPATHIES; CELL SURVIVAL; FIBROBLASTS; HYDROGEN PEROXIDE; MICE; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PROTECTIVE AGENTS; RECEPTOR, CANNABINOID, CB2; VENTRICULAR DYSFUNCTION, LEFT;

EID: 68549123561     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-129478     Document Type: Article

References (50)

1. Braunwald, E., and Pfeffer, M. A. (1991) Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am. J. Cardiol. 68, 1D-6D
2. Frangogiannis, N. G. (2008) The immune system and cardiac repair. Pharmacol. Res. 58, 88-111
3. Duran, W. N. (2008) The double-edge sword of TNF-α in ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 295, H2221-H2222
4. Gao, X., Zhang, H., Belmadani, S., Wu, J., Xu, X., Elford, H., Potter, B. J., and Zhang, C. (2008) Role of TNF-α-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 295, H2242-H2249
5. Mann, D. L. (2003) Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 65, 81-101
6. Pacher, P., Batkai, S., and Kunos, G. (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389-462 (Pubitemid 44394908)
7. Lépicier, P., Bibeau-Poirier, A., Lagneux, C., Servant, M. J., and Lamontagne, D. (2006) Signaling pathways involved in the cardioprotective effects of cannabinoids. J. Pharm. Sci. 102, 155-166 (Pubitemid 44690972)
8. Mach, F., Montecucco, F., and Steffens, S. (2008) Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br. J. Pharmacol. 153, 290-298
9. Pacher, P., and Hasko, G. (2008) Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 153, 252-262
10. Randall, M. D., Kendall, D. A., and O'Sullivan, S. (2004) The complexities of the cardiovascular actions of cannabinoids. Br. J. Pharmacol. 142, 20-26
11. Duffy, D., and Rader, D. (2007) Endocannabinoid antagonism: blocking the excess in the treatment of high-risk abdominal obesity. Trends Cardiovasc. Med. 17, 35-43 (Pubitemid 46210169)
12. Lepicier, P., Lagneux, C., Sirois, M. G., and Lamontagne, D. (2007) Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts. Life Sci. 81, 1373-1380 (Pubitemid 47599529)
13. Wagner, J. A., Hu, K., Bauersachs, J., Karcher, J., Wiesler, M., Goparaju, S. K., Kunos, G., and Ertl, G. (2001) Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J. Am. Coll. Cardiol. 38, 2048-2054 (Pubitemid 33116583)
14. Joyeux, M., Arnaud, C., Godin-Ribuot, D., Demenge, P., Lamontagne, D., and Ribuot, C. (2002) Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. Cardiovasc. Res. 55, 619-625 (Pubitemid 34874956)
15. Lagneux, C., and Lamontagne, D. (2001) Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br. J. Pharmacol. 132, 793-796 (Pubitemid 32193634)
16. Liu, J., Batkai, S., Pacher, P., Harvey-White, J., Wagner, J. A., Cravatt, B. F., Gao, B., and Kunos, G. (2003) Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor. J. Biol. Chem. 278, 45034-45039 (Pubitemid 37377264)
17. Di Filippo, C., Rossi, F., Rossi, S., and D'Amico, M. (2004) Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. J. Leukoc. Biol. 75, 453-459 (Pubitemid 38316376)
18. Buckley, N. E. (2008) The peripheral cannabinoid receptor knockout mice: an update. Br. J. Pharmacol. 153, 309-318
19. Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., and Lotersztajn, S. (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128, 742-755 (Pubitemid 40585376)
20. 8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem. 7, 2905-2914
21. Pertwee, R. G., and Ross, R. A. (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids 66, 101-121
22. Idris, A. I., Sophocleous, A., Landao-Bassonga, E., van't Hof, R. J., and Ralston, S. H. (2008) Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology 149, 5619-5626
23. Rajesh, M., Mukhopadhyay, P., Batkai, S., Hasko, G., Liaudet, L., Huffman, J. W., Csiszar, A., Ungvari, Z., Mackie, K., Chatterjee, S., and Pacher, P. (2007) CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte- endothelial adhesion. Am. J. Physiol. Heart Circ. Physiol. 293, H2210-H2218 (Pubitemid 47605864)
24. Beggah, A. T., Escoubet, B., Puttini, S., Cailmail, S., Delage, V., Ouvrard-Pascaud, A., Bocchi, B., Peuchmaur, M., Delcayre, C., Farman, N., and Jaisser, F. (2002) Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 99, 7160-7165 (Pubitemid 34526272)
25. Billet, S., Bardin, S., Verp, S., Baudrie, V., Michaud, A., Conchon, S., Muffat-Joly, M., Escoubet, B., Souil, E., Hamard, G., Bernstein, K. E., Gasc, J. M., Elghozi, J. L., Corvol, P., and Clauser, E. (2007) Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J. Clin. Invest. 117, 1914-1925 (Pubitemid 47036325)
26. Sambrano, G. R., Fraser, I., Han, H., Ni, Y., O'Connell, T., Yan, Z., and Stull, J. T. (2002) Navigating the signalling network in mouse cardiac myocytes. Nature 420, 712-714 (Pubitemid 36764508)
27. Defer, N., Azroyan, A., Pecker, F., and Pavoine, C. (2007) TNFR1 and TNFR2 signaling interplay in cardiac myocytes. J. Biol. Chem. 282, 35564-35573 (Pubitemid 350277148)
28. Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J., and Entman, M. L. (2007) Critical role of monocyte chemoattractant protein- 1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115, 584-592 (Pubitemid 46226168)
29. Bourraindeloup, M., Adamy, C., Candiani, G., Cailleret, M., Bourin, M. C., Badoual, T., Su, J. B., Adubeiro, S., Roudot- Thoraval, F., Dubois-Rande, J. L., Hittinger, L., and Pecker, F. (2004) N-Acetylcysteine treatment normalizes serum tumor necrosis factor-α level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110, 2003-2009 (Pubitemid 39331914)
30. 2-adrenergic cardiac effects in rat. J. Biol. Chem. 280, 18881-18890
31. Cailleret, M., Amadou, A., Andrieu-Abadie, N., Nawrocki, A., Adamy, C., Ait-Mamar, B., Rocaries, F., Best-Belpomme, M., Levade, T., Pavoine, C., and Pecker, F. (2004) N-Acetylcysteine prevents the deleterious effect of tumor necrosis factor-α on calcium transients and contraction in adult rat cardiomyocytes. Circulation 109, 406-411 (Pubitemid 38133911)
32. Shivakumar, K., Sollott, S. J., Sangeetha, M., Sapna, S., Ziman, B., Wang, S., and Lakatta, E. G. (2008) Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 294, H2653-H2658
33. Yellon, D. M., and Hausenloy, D. J. (2007) Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121-1135
34. Gottlieb, R. A., and Engler, R. L. (1999) Apoptosis in myocardial ischemia-reperfusion. Ann. N. Y. Acad. Sci. 874, 412-426
35. Yaoita, H., Ogawa, K., Maehara, K., and Maruyama, Y. (1998) Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97, 276-281 (Pubitemid 28067314)
36. Condorelli, G., Roncarati, R., Ross, J., Jr., Pisani, A., Stassi, G., Todaro, M., Trocha, S., Drusco, A., Gu, Y., Russo, M. A., Frati, G., Jones, S. P., Lefer, D. J., Napoli, C., and Croce, C. M. (2001) Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc. Natl. Acad. Sci. U. S. A. 98, 9977-9982 (Pubitemid 32769413)
37. Donath, S., Li, P., Willenbockel, C., Al-Saadi, N., Gross, V., Willnow, T., Bader, M., Martin, U., Bauersachs, J., Wollert, K. C., Dietz, R., and von Harsdorf, R. (2006) Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 113, 1203-1212 (Pubitemid 43754246)
38. Mann, D. L., McMurray, J. J., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., Krum, H., Liu, P., Nieminen, M., Tavazzi, L., van Veldhuisen, D. J., Waldenstrom, A., Warren, M., Westheim, A., Zannad, F., and Fleming, T. (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109, 1594-1602 (Pubitemid 38451714)
39. Sarkar, S., Vellaichamy, E., Young, D., and Sen, S. (2004) Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am. J. Physiol. Heart Circ. Physiol. 287, H107-H117 (Pubitemid 38802342)
40. Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., Wang, X. F., and Frangogiannis, N. G. (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116, 2127-2138 (Pubitemid 350060350)
41. Ikeuchi, M., Tsutsui, H., Shiomi, T., Matsusaka, H., Matsushima, S., Wen, J., Kubota, T., and Takeshita, A. (2004) Inhibition of TGF-α signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc. Res. 64, 526-535 (Pubitemid 39505431)
42. Lotersztajn, S., Teixeira-Clerc, F., Julien, B., Deveaux, V., Ichigotani, Y., Manin, S., Tran-Van-Nhieu, J., Karsak, M., Zimmer, A., and Mallat, A. (2008) CB2 receptors as new therapeutic targets for liver diseases. Br. J. Pharmacol. 153, 286-289
43. Mallat, A., and Lotersztajn, S. (2008) Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G9-G12
44. Teixeira-Clerc, F., Julien, B., Grenard, P., Tran Van Nhieu, J., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., and Lotersztajn, S. (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12, 671-676 (Pubitemid 43865236)
45. Batkai, S., Mukhopadhyay, P., Harvey-White, J., Kechrid, R., Pacher, P., and Kunos, G. (2007) Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am. J. Physiol. Heart Circ. Physiol. 293, H1689-H1695 (Pubitemid 47367216)
46. Gaskari, S. A., Liu, H., Moezi, L., Li, Y., Baik, S. K., and Lee, S. S. (2005) Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br. J. Pharmacol. 146, 315-323 (Pubitemid 41486673)
47. Mukhopadhyay, P., Batkai, S., Rajesh, M., Czifra, N., Harvey- White, J., Hasko, G., Zsengeller, Z., Gerard, N. P., Liaudet, L., Kunos, G., and Pacher, P. (2007) Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J. Am. Coll. Cardiol. 50, 528-536 (Pubitemid 47126779)
48. Batkai, S., Rajesh, M., Mukhopadhyay, P., Hasko, G., Liaudet, L., Cravatt, B. F., Csiszar, A., Ungvari, Z., and Pacher, P. (2007) Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am. J. Physiol. Heart Circ. Physiol. 293, H909-H918 (Pubitemid 47254186)
49. Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Karsak, M., Zimmer, A., Frossard, J. L., and Mach, F. (2005) Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434, 782-786 (Pubitemid 44739523)
50. Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., and Kunos, G. (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem. J. 346(Pt. 3), 835-840 (Pubitemid 30171048)